Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Syed Faizan
Institutions:
JSS Academy of Higher Education and Research,
JSS College of Pharmacy
Observed institutions:
JSS Academy of Higher Education and Research,
JSS College of Pharmacy
ORCID:
0000-0001-6104-0557
Observed ORCID:
0000-0001-6104-0557
OpenAlex ID:
A5045168285
A century-old one-pot multicomponent Biginelli reaction products still finds a niche in drug discoveries: Synthesis, mechanistic studies and diverse biological activities of dihydropyrimidines
2023
·
Syed Faizan
, Tamsheel Fatima Roohi
, et al.
·
Journal of Molecular Structure
·
55
Quinone scaffolds as potential therapeutic anticancer agents: Chemistry, mechanism of Actions, Structure-Activity relationships and future perspectives
2024
·
Syed Faizan
, Maged Mohammed Abdo Mohsen
, et al.
·
Results in Chemistry
·
48
Design, Synthesis, Analysis, Evaluation of Cytotoxicity Against MCF-7 Breast Cancer Cells, 3D QSAR Studies and EGFR, HER2 Inhibition Studies on Novel Biginelli 1,4-Dihydropyrimidines
2022
·
Namburu Lalitha Naishima
, Syed Faizan
, et al.
·
Journal of Molecular Structure
·
32
Novel derivatives of eugenol as potent anti-inflammatory agents via PPARγ agonism: rational design, synthesis, analysis, PPARγ protein binding assay and computational studies
2022
·
Noor Fathima Anjum
, Dhivya Shanmugarajan
, et al.
·
RSC Advances
·
27
PDF
Beyond Glucose: The Dual Assault of Oxidative and ER Stress in Diabetic Disorders
2023
·
Tamsheel Fatima Roohi
, Syed Faizan
, et al.
·
High Blood Pressure & Cardiovascular Prevention
·
26
Design, parallel synthesis of Biginelli 1,4-dihydropyrimidines using PTSA as a catalyst, evaluation of anticancer activity and structure activity relationships via 3D QSAR studies
2021
·
Syed Faizan
, B.R. Prashantha Kumar
, et al.
·
Bioorganic Chemistry
·
23
Novel Derivatives of Eugenol as a New Class of PPARγ Agonists in Treating Inflammation: Design, Synthesis, SAR Analysis and In Vitro Anti-Inflammatory Activity
2023
·
Noor Fathima Anjum
, Dhivya Shanmugarajan
, et al.
·
Molecules
·
18
PDF
Novel dihydropyrimidines as promising EGFR & HER2 inhibitors: Insights from experimental and computational studies
2024
·
Syed Faizan
, Adil Farooq Wali
, et al.
·
European Journal of Medicinal Chemistry
·
15
Beyond drug discovery: Exploring the physiological and methodological dimensions of zebrafish in diabetes research
2024
·
Tamsheel Fatima Roohi
, Syed Faizan
, et al.
·
Experimental Physiology
·
15
PDF
N-Substituted dihydropyridines as promising EGFR tyrosine kinase inhibitors against breast cancer: Design, synthesis, biological evaluation, docking, and molecular dynamics simulations
2024
·
Syed Faizan
, Umme Hani
, et al.
·
Results in Chemistry
·
14
Rational design, molecular docking, dynamic simulation, synthesis, PPAR-γ competitive binding and transcription analysis of novel glitazones
2022
·
Ashwini Prem Kumar
, Subhankar Mandal
, et al.
·
Journal of Molecular Structure
·
14
Biomarkers and signaling pathways of diabetic nephropathy and peripheral neuropathy: possible therapeutic intervention of rutin and quercetin
2023
·
Tamsheel Fatima Roohi
, Seema Mehdi
, et al.
·
Diabetology International
·
12
PDF
Anticancer potential of novel symmetrical and asymmetrical dihydropyridines against breast cancer via EGFR inhibition: molecular design, synthesis, analysis and screening
2024
·
Syed Faizan
, Sirajunisa Talath
, et al.
·
RSC Advances
·
11
PDF
A promising in silico protocol to develop novel PPARγ antagonists as potential anticancer agents: Design, synthesis and experimental validation via PPARγ protein activity and competitive binding assay
2021
·
Yuvaraj Sivamani
, Dhivya Shanmugarajan
, et al.
·
Computational Biology and Chemistry
·
10
A multifaceted approach for the development of novel Hantzsch 1,4-dihydropyridines as anticancer agents: Rational design, parallel synthesis, analysis, cytotoxicity and EGFR/HER2 inhibition studies
2024
·
A.S.V.L. Sruthi
, Syed Faizan
, et al.
·
Results in Chemistry
·
9
Molecular dynamics articulated multilevel virtual screening protocol to discover novel dual PPAR α/γ agonists for anti-diabetic and metabolic applications
2022
·
Subhankar Mandal
, Syed Faizan
, et al.
·
Molecular Diversity
·
9
Enantioselective Separation and Pharmacokinetics of a Chiral 1,4‐Dihydropyrimidine Derivative in Rats: A Combined Chromatography and Docking Approach
2024
·
Chiriki Devi Sri
, Syed Faizan
, et al.
·
Chirality
·
4
Quinones as promising agents for managing metabolic syndrome: Therapeutic and toxicological considerations
2025
·
Tamsheel Fatima Roohi
, Zahoor Ahmad Parray
, et al.
·
Biochemical and Biophysical Research Communications
·
2
Advances in Understanding Cellular Mechanisms of Cardiovascular Complications and Retinopathy in Diabetes: Therapeutic Potential of Phytochemicals
2023
·
Tamsheel Fatima Roohi
, Syed Faizan
, et al.
·
Iterative International Publishers eBooks
Novel Biginelli Dihydropyrimidines as EGFR & HER2 Inhibitors: Design, Synthesis, Analysis, Evaluation and Structure Activity Relationships Via CoMSIA Studies
2023
·
Syed Faizan
, Aishwarya S
, et al.
·
SSRN Electronic Journal
Show more works
View as search
Works count:
20
Citation count:
344
H-index:
12
I10-index:
14
Year
Topic
Type